Liver

98 drugs in development·62 companies·1 clinical trial

Drug Pipeline by Phase

Approved(14)

Drug	Company
AMNIOFIX	MiMedx Group Inc (MDXG)
avatrombopag	GYRE THERAPEUTICS, INC. (GYRE)
Cabometyx/Cometriq	Royalty Pharma plc (RPRX)
contiva	GYRE THERAPEUTICS, INC. (GYRE)
deferasirox	Amneal Pharmaceuticals, Inc. (AMRX)
doptelet	AKORN INC (AKRX)
felbamate	ANI PHARMACEUTICALS INC (ANIP)
graftassurecore	Insight Molecular Diagnostics Inc. (IMDX)
mycophenolate mofetil	Amneal Pharmaceuticals, Inc. (AMRX)
orbera	Apollo Endosurgery, Inc. (APEN)
Remunity Pump for Remodulin	UNITED THERAPEUTICS Corp (UTHR)
Rezdiffra	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
tacrolimus	Mylan II B.V. (MYL)
tacrolimus	NEXUS BIOPHARMA INC (NEXS)

Phase 3(13)

Drug	Company
100 mg resmetirom	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
etavopivat	Novo Nordisk A/S (NVO)
Fazirsiran	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
hydronidone	GYRE THERAPEUTICS, INC. (GYRE)
Lepodisiran Sodium	ELI LILLY & Co (LLY)
maralixibat	Mirum Pharmaceuticals, Inc. (MIRM)
nnc0560-0004	Novo Nordisk A/S (NVO)
nofazinlimab	EQRx, Inc. (EQRX)
Pegozafermin	89bio, Inc. (ETNB)
Resmetirom	MADRIGAL PHARMACEUTICALS, INC. (MDGL)
smt + pe-a 5%	Grifols S.A. (GRFS)
smt + pe-a 5%	Grifols SA (GIKLY)

Phase 2(15)

Drug	Company
AZD2389	ASTRAZENECA PLC (AZN)
Cholates	Mirum Pharmaceuticals, Inc. (MIRM)
f573	GYRE THERAPEUTICS, INC. (GYRE)
gb1211	Damora Therapeutics, Inc. (DMRA)
GSK-4532990	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
MiMedx AmnioFix	MiMedx Group Inc (MDXG)
nnc0194-0499	Novo Nordisk A/S (NVO)
pemvidutide	Altimmune, Inc. (ALT)
pemvidutide (ALT-801)	Altimmune, Inc. (ALT)
pemvidutide (formerly ALT-801)	Altimmune, Inc. (ALT)
PLN-1474	PLIANT THERAPEUTICS, INC. (PLRX)
Rencofilstat (formerly CRV431; CPI-431-32)	Hepion Pharmaceuticals, Inc. (CTRVP)
rencofilstat (formerly CRV431)	Hepion Pharmaceuticals, Inc. (CTRVP)
tesamorelin	IO Biotech, Inc. (IOBT)
tvb-2640	Sagimet Biosciences Inc. (SGMT)

Phase 1(17)

Drug	Company
ADG126	Adagene Inc. (ADAG)
Allogeneic Umbilical Cord Mesenchymal Stem Cell	Accustem Sciences Inc. (ACUT)
aln-cideb	REGENERON PHARMACEUTICALS, INC. (REGN)
lepodisiran	ELI LILLY & Co (LLY)
miroliver	Miromatrix Medical Inc. (MIRO)
miroliverelap	Miromatrix Medical Inc. (MIRO)
multiple dosing of g1090n	Genfit S.A. (GNFT)
NKT2152	Adagene Inc. (ADAG)
nnc4005-001	Novo Nordisk A/S (NVO)
QEL-001	Coya Therapeutics, Inc. (COYA)
sd-101	TriSalus Life Sciences Inc. (TLSI)
SER-147	Seres Therapeutics, Inc. (MCRB)
single dose g1090n	Genfit S.A. (GNFT)
ThecaFlex DRx	BIOGEN INC. (BIIB)
Tiragolumab	Adagene Inc. (ADAG)
Tocilizumab	Adagene Inc. (ADAG)
TPST-1120	Adagene Inc. (ADAG)

Preclinical(19)

Drug	Company
188rnl-bam	PLUS THERAPEUTICS Inc. (PSTV)
a2342	ALBIREO PHARMA, INC. (ALBO)
a3907	ALBIREO PHARMA, INC. (ALBO)
AGTX-2003 (RTI-1092769)	Agentix Corp. (AGTX)
aln1003	Alaunos Therapeutics, Inc. (TCRT)
ATYR0101	aTYR PHARMA INC (ATYR)
ATYR0750	aTYR PHARMA INC (ATYR)
Base editing therapies (C3 and complement targets)	Apellis Pharmaceuticals, Inc. (APLS)
CT-2401	Carisma Therapeutics Inc. (CARM)
electroceuticals therapeutic devices	ENDONOVO THERAPEUTICS, INC. (ENDV)
exoaso-stat6	Codiak BioSciences, Inc. (CDAK)
f351	GYRE THERAPEUTICS, INC. (GYRE)
jkb-122	Biostax Corp. (BTAX)
k1.1	SUNSHINE BIOPHARMA INC. (SBFM)
longevity	Korro Bio, Inc. (KRRO)
siRNA targeting Beta2-spectrin	Bullfrog AI Holdings Inc. (BFRG)
Small molecule IFNAR agonist program	ASSEMBLY BIOSCIENCES, INC. (ASMB)
STAC-BBB	SANGAMO THERAPEUTICS, INC (SGMO)
uttroside-b	Q BioMed Inc. (QBIO)

Unknown(13)

Drug	Company
Effin'	Ascend Wellness Holdings, Inc. (AAWH)
Helix™ minimally invasive intramyocardial therapeutic delivery platform	BioCardia, Inc. (BCDA)
Heptral™	ABBOTT LABORATORIES (ABT)
legalon	Mylan II B.V. (MYL)
Pacha 12mL Disposable	Charlie's Holdings, Inc. (CHUC)
Pacha 4mL Disposable	Charlie's Holdings, Inc. (CHUC)
Pacha 8mL Disposable	Charlie's Holdings, Inc. (CHUC)
Pacha Syn 4mL Disposable	Charlie's Holdings, Inc. (CHUC)
Pacha Syn 8mL Disposable	Charlie's Holdings, Inc. (CHUC)
Pachamama 2mL Disposable	Charlie's Holdings, Inc. (CHUC)
Samyr™	ABBOTT LABORATORIES (ABT)
Transmetil™	ABBOTT LABORATORIES (ABT)
VeganHepplus™	BIOADAPTIVES, INC. (BDPT)

N/A(1)

Drug	Company
Midodrine	Valneva SE (VALN)

Phase 1/Phase 2(3)

Drug	Company
aln-pnp	REGENERON PHARMACEUTICALS, INC. (REGN)
KB407	Krystal Biotech, Inc. (KRYS)
WVE-008	Wave Life Sciences Ltd. (WVE)

Phase 4(3)

Drug	Company
cagrilintide + semaglutide	Novo Nordisk A/S (NVO)
Leucovorin	IGM Biosciences, Inc. (IGMS)
LIVMARLI (maralixibat)	Mirum Pharmaceuticals, Inc. (MIRM)

BioSniper tracks 98 drugs in development for Liver across 62 companies.

There are 1 clinical trial targeting Liver tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.